Whether an optimal strategy exists for VTE prevention in critically ill patients: Insights from guidelines and randomized controlled trials

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a significant concern in critically ill patients. Effective prevention is vital due to its high incidence [1,2]. However, the presence of both high VTE and bleeding risks complicates the development of effective prevention strategies [3].